Compare STOK & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | STOK | JJSF |
|---|---|---|
| Founded | 2014 | 1971 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Specialty Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.7B | 1.7B |
| IPO Year | 2019 | N/A |
| Metric | STOK | JJSF |
|---|---|---|
| Price | $33.14 | $91.00 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | $31.00 | ★ $138.33 |
| AVG Volume (30 Days) | ★ 880.4K | 310.0K |
| Earning Date | 11-04-2025 | 11-17-2025 |
| Dividend Yield | N/A | ★ 3.52% |
| EPS Growth | ★ N/A | N/A |
| EPS | 0.68 | ★ 3.36 |
| Revenue | $205,632,000.00 | ★ $3,166,466,000.00 |
| Revenue This Year | $430.24 | $4.28 |
| Revenue Next Year | N/A | $2.24 |
| P/E Ratio | $45.09 | ★ $27.02 |
| Revenue Growth | ★ 1128.17 | 0.54 |
| 52 Week Low | $5.35 | $80.67 |
| 52 Week High | $38.69 | $172.33 |
| Indicator | STOK | JJSF |
|---|---|---|
| Relative Strength Index (RSI) | 65.66 | 52.22 |
| Support Level | $28.74 | $90.24 |
| Resistance Level | $31.44 | $94.05 |
| Average True Range (ATR) | 1.83 | 2.57 |
| MACD | 0.38 | 0.47 |
| Stochastic Oscillator | 95.76 | 67.00 |
Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.
J&J Snack Foods Corp manufactures, markets, and distributes snack foods and beverages to foodservice and retail supermarket outlets. The company's products include frozen beverages, juice, fruit bars, sorbet, cakes, and cookies that are distributed to various consumers, including restaurants, supermarkets, convenience stores, universities, theaters, and theme parks. The company operates in three business segments: food service, which sells snacks, desserts, and baked goods at the point-of-sale; retail supermarkets, which sells frozen and prepackaged products to supermarkets; and frozen beverages, which sells frozen beverages under brands Icee, Slush puppie, and Parrot ice in the United States, Mexico, and Canada.